Drug Shortage Report for BETASERON
Report ID | 162399 |
Drug Identification Number | 02169649 |
Brand name | BETASERON |
Common or Proper name | INTERFERON BETA-1B |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | INTERFERON BETA-1B |
Strength(s) | 0.3MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 15 Single Use Pack |
ATC code | L03AB |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-07-01 |
Actual start date | |
Estimated end date | 2022-07-05 |
Actual end date | 2022-06-28 |
Shortage status | Avoided shortage |
Updated date | 2022-06-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-06-10 | English | Compare |
v2 | 2022-06-10 | French | Compare |
v3 | 2022-06-28 | English | Compare |
v4 | 2022-06-28 | French | Compare |
Showing 1 to 4 of 4